Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Thyroid Neoplasms × Digoxin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Neoplasms 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Melanoma 2 Healthy Participants 2 Carcinoma, Non-Small-Cell Lung 2 Advanced Solid Tumor 2 cMET-dysregulated Advanced Solid Tumors 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Solid Tumor 1 Neoplastic Cells, Circulating 1 Liver Cirrhosis 1

Interventions

Iodine-131 10 lenvatinib 6 Thyrotropin Alfa 6 Sorafenib 6 vandetanib 5 Thyroidectomy 5 Sunitinib 5 Saline Solution 5 pazopanib 4 Triiodothyronine 4 Thyroxine 3 Everolimus 3 Dexmedetomidine 3 Control Groups 3 belinostat 2 Vemurafenib 2 Trastuzumab 2 Surveys and Questionnaires 2 Surgical Procedures, Operative 2 Paclitaxel 2 Immunohistochemistry 2 Gefitinib 2 Calcium Carbonate 2 Bupivacaine 2 Bortezomib 2 Azacitidine 2 Axitinib 2 AZD 6244 2 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 trametinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05507775 2024-04-11

DIGUP-TC

Radboud University Medical Center

Phase NA Completed

EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡